IGEA PHARMA N overview

IGEA Pharma N.V. / Key word(s): AGMEGM/AGMEGM IGEA Pharma N.V.: IGEA announces annual General Meeting Resolutions 13-Nov-2023 / 19:35 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. IGEA announces annual General Meeting Resolutions Hoofddorp, the Netherlands, 13 November 2023. IGEA Pharma N.V. (SIX: IGPH) announced the annual General Meeting Resolution. Hoofddorp, the Netherlands, 13 November 2023 . IGEA...

IGEA Pharma N.V. / Key word(s): Letter of Intent/Letter of Intent IGEA Pharma N.V.: IGEA to update on RBCARE business combination 09-Oct-2023 / 22:50 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR...

IGEA Pharma N.V. / Key word(s): Agreement/Agreement IGEA Pharma N.V.: IGEA and RBCARE2023 signed to combine their businesses 03-Oct-2023 / 23:55 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR...

IGEA Pharma N.V. / Key word(s): Half Year Results/Half Year Results IGEA Pharma N.V.: IGEA discloses its half-year figures 2023 30-Sep-2023 / 19:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. IGEA discloses its half-year figures 2023 Hoofddorp, the Netherlands, 30 September2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its unaudited interim financial statements as of 30 June 2023....

IGEA Pharma N.V. / Key word(s): AGMEGM/AGMEGM IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V. 28-Sep-2023 / 19:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Convening notice 28 SEPTEMBER 2023 Dear Shareholder, The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby invites you to attend the Annual General Meeting on...

IGEA Pharma N.V. / Key word(s): Delisting/Delisting IGEA Pharma N.V.: IGEA filed the appeal on SIX decision of delisting 30-Aug-2023 / 22:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. IGEA filed the appeal on SIX decision of delisting Hoofddorp, the Netherlands, 30 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the filing of the appeal to the decision of the SIX to delist the company. The...

IGEA Pharma N.V. / Key word(s): Delisting/Delisting IGEA Pharma N.V.: IGEA to update on SIX decision 04-Aug-2023 / 22:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. IGEA to update on SIX decision Hoofddorp, the Netherlands, 4 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the intention to appeal the decision of the SIX to delist the company. The new board of directors entered in charge by end...

IGEA Pharma N.V. / Key word(s): Annual Results/Annual Results IGEA Pharma N.V.: IGEA discloses its Annual Report 2022 31-Jul-2023 / 00:35 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. IGEA discloses its Annual Report 2022 Hoofddorp, the Netherlands, 30 July 2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its Annual Report 2022. Overview 2022 The Group did not start to generate revenue in the...